Meta-analyses have consistently demonstrated elevated levels of inflammatory markers, such as interleukins and C-reactive protein, in patients with depression, underscoring the role of inflammation in its development (14, 15, 47). This evidence concerns the gene CRP and depressive symptom measurement.